UP-TO-DATE, RESEARCH BASED INFORMATION ABOUT PSYCHEDELICS.
Sustained effects of single doses of classical psychedelics in humans
A unique and compelling feature of psychedelics is that intake of just a single psychedelic dose is associated with long-lasting effects.
Language models learn sentiment and substance from 11,000 psychoactive experiences
MDMA was singularly linked to mid-experience swelling of "Love", potent psychedelics like DMT, and 5-MeO-DMT were associated with "Mystical Experiences".
MDMA-assisted therapy for posttraumatic stress disorder: A pooled analysis of ethnoracial differences in efficacy and safety from two Phase 2 open-label lead-in trials and a Phase 3 randomized, blinded placebo-controlled trial
These findings provide preliminary support for the efficacy and safety of MDMA-AT for treating PTSD across ethnoracial groups.
Studying close entity encounters of the psychedelic kind: Insights from the cognitive evolutionary science of religion
This article focuses on lessons learned by CESR (cognitive-evolutionary science of religion) scholars that might provide inspiration for scholars in SPE (science of psychedelic experiences)
Ketamine for bipolar depression: Biochemical, psychotherapeutic, and psychedelic approaches
This article expands on the existing research by articulating three different paradigms for ketamine treatment: biochemical, psychotherapeutic, and psychedelic.
Positive psychology & psychedelics: possible synergies
MDMA-assisted approaches can turbo-charge savouring/compassion/gratitude positive affect treatments.
Braxia Scientific presents positive preliminary findings from phase II randomized, multi-dose clinical trial of psilocybin-assisted therapy for treatment resistant depression
Positive preliminary results from the first Health Canada Approved, Phase II, randomized clinical trial to evaluate psilocybin-assisted therapy for Treatment-Resistant-Depression.
Psychedelics as preventive treatment in headache and chronic pain disorders
The effects of psychedelic drugs in headache and chronic pain disorders have been reported for several decades, and now controlled studies are emerging.
Serotonergic psychedelic treatment for obesity and eating disorders: potential expectations and caveats for emerging studies
Given the potential direct and indirect effects of psychedelic treatment on food intake, there is a lot of excitement for its use as a novel therapeutic.
Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD)
The results suggest that LSD is a relatively safe drug in recreational settings. Adverse reactions are typically short-lived, self-limiting and psychological in nature.
Psychedelic assisted therapy for major depressive disorder: Recent work and clinical directions
We conclude that combination psychedelic treatment and psychotherapy facilitate more enduring and profound antidepressant effects than produced by ketamine or psilocybin alone.
MDMA for the treatment of negative symptoms in schizophrenia
This review provides a rationale for the use of MDMA in the treatment of negative symptoms by reviewing the literature on negative symptoms, their treatment, MDMA, and MDMA-assisted therapy.
Psychedelic-assisted psychotherapy — A systematic review of associated psychological interventions
The aim of this paper is to construct a picture of what models of psychedelic-assisted psychotherapy are currently adopted in clinical research and to report on their clinical outcomes.
Systematic review of psychometric instruments used in research with psychedelics
This study aims to review which psychometric instruments are available to assess subjective states induced by psychedelics.
Ayahuasca and public health II: Health status in a large sample of ayahuasca-ceremony participants in the Netherlands
Our findings suggest that regular participation in ayahuasca ceremonies is not linked to relevant health harms.
Phenomenology and content of the inhaled N, N-dimethyltryptamine (N, N-DMT) experience
Understanding the phenomenology and content of the inhaled N, N, dimethyltryptamine (N, N-DMT) experience